Suppr超能文献

印度癌症患者对传统、补充和替代医学(TCAM)的使用以及就医延迟情况。

Indian Cancer Patients' use of Traditional, Complementary and Alternative Medicine (TCAM) and delays in presentation to Hospital.

作者信息

Broom Alex, Nayar Kr, Tovey Philip, Shirali Rashmi, Thakur Rakesh, Seth Tulika, Chhetri Prem

出版信息

Oman Med J. 2009 Apr;24(2):99-102. doi: 10.5001/omj.2009.24.

Abstract

OBJECTIVES

A majority of Indian cancer patients are often presented with incurable diseases at the latest phase of disease progression. The use of traditional, complementary and alternative medicine (TCAM) has been identified by Indian oncologists as a potential factor for the delay in seeking health from medical practitioners but no research has been conducted to verify such claims. The aim of this study is to identify socio-demographic and disease status differences between TCAM and non-TCAM users among cancer patients in India and associated patterns of seeking professional medical help.

METHODS

A random survey of 825 cancer patients in one public and one private hospital was conducted in Delhi, India. Using four interviewers, a list sampling technique was used to interview every patient over a four month period, with a response rate of 80%.

RESULTS

The results showed that 34.3% of cancer patients had used TCAM. The results also demonstrated a statistically significant relationship between the use of TCAM and reported delay in seeking help from clinical medicine (p<0.001). On the other hand, 35.2% of TCAM users reported seeking help immediately after onset of symptoms, whereas 50% of non-users immediately sought help from conventional medicine. Furthermore, 11.5% of TCAM users reported waiting for six months or more after noticing cancer-related symptoms, while only 2.1% of non-users waited this long.

CONCLUSION

Overall, early diagnosis and intervention is critical for effective treatment of many malignancies. Delays in presentation related to the use of TCAM may be an important factor relating to the high rates of advanced disease on presentation and low survival rates in the care of Indian cancer patients. Further research is needed to explore the reasons for using TCAM and to ensure existing issues of delays in help seeking are addressed.

摘要

目的

大多数印度癌症患者在疾病进展的最后阶段往往被诊断为患有无法治愈的疾病。印度肿瘤学家已将使用传统、补充和替代医学(TCAM)视为患者延迟寻求医疗从业者帮助的一个潜在因素,但尚未进行研究来验证此类说法。本研究的目的是确定印度癌症患者中使用TCAM和不使用TCAM的人群在社会人口统计学和疾病状况方面的差异,以及寻求专业医疗帮助的相关模式。

方法

在印度德里的一家公立医院和一家私立医院对825名癌症患者进行了随机调查。使用四名访谈员,采用列表抽样技术在四个月的时间里对每位患者进行访谈,回复率为80%。

结果

结果显示,34.3%的癌症患者使用过TCAM。结果还表明,使用TCAM与报告的延迟寻求临床医学帮助之间存在统计学上的显著关系(p<0.001)。另一方面,35.2%的TCAM使用者报告在症状出现后立即寻求帮助,而50%的非使用者立即寻求传统医学的帮助。此外,11.5%的TCAM使用者报告在注意到癌症相关症状后等待了六个月或更长时间,而只有2.1%的非使用者等待了这么久。

结论

总体而言,早期诊断和干预对于有效治疗许多恶性肿瘤至关重要。与使用TCAM相关的就诊延迟可能是印度癌症患者就诊时晚期疾病发生率高和生存率低的一个重要因素。需要进一步研究以探讨使用TCAM的原因,并确保解决现有的寻求帮助延迟问题。

相似文献

4
Prevalence of the use of traditional complementary and alternative medicine amongst cancer patients in a tertiary care center in Kerala, India.
J Ayurveda Integr Med. 2021 Apr-Jun;12(2):359-364. doi: 10.1016/j.jaim.2021.04.011. Epub 2021 May 18.
5
Prevalence of traditional, complementary, and alternative medicine (TCAM) among adult cancer patients in Malawi.
Cancer Causes Control. 2022 Aug;33(8):1047-1057. doi: 10.1007/s10552-022-01563-0. Epub 2022 Apr 13.
7
An Empirical Study on Traditional, Complementary and Alternative Medicine Usage among Malaysian Cancer Patients.
Asian Pac J Cancer Prev. 2015;16(15):6237-41. doi: 10.7314/apjcp.2015.16.15.6237.
9
The dynamics of TCAM integration in the Indian public health system: Medical dominance, countervailing power and co-optation.
Soc Sci Med. 2021 Oct;286:114152. doi: 10.1016/j.socscimed.2021.114152. Epub 2021 Jun 18.

引用本文的文献

2
The Role of Ayurveda in Prostate Cancer Management.
Integr Cancer Ther. 2025 Jan-Dec;24:15347354251330906. doi: 10.1177/15347354251330906. Epub 2025 Mar 29.
3
Factors influencing delayed cancer health seeking in Meghalaya, Northeast India: A qualitative study.
Indian J Med Res. 2024 Aug;160(2):201-209. doi: 10.25259/ijmr_2136_23.
4
Improving Access and Health Outcomes in Palliative Care through Cultural Competence: An exploration of opportunities and challenges in India.
Indian J Palliat Care. 2022 Oct-Dec;28(4):331-337. doi: 10.25259/IJPC_21_21. Epub 2022 Aug 25.
6
Challenges in the Management of Lung Cancer: Real-World Experience from a Tertiary Center in South India.
South Asian J Cancer. 2021 Dec 20;10(3):175-182. doi: 10.1055/s-0041-1733312. eCollection 2021 Sep.
7
Use of complementary and alternative medicine among patients with cancer in a sub-Himalayan state in India: An exploratory study.
J Ayurveda Integr Med. 2021 Jan-Mar;12(1):126-130. doi: 10.1016/j.jaim.2021.01.001. Epub 2021 Feb 23.
8
Epidemiology, Clinical Characteristics, and Prognostic Factors in Critically Ill Patients with Hematolymphoid Malignancy.
Indian J Crit Care Med. 2021 Jan;25(1):56-61. doi: 10.5005/jp-journals-10071-23469.
9
Role of integrative medicine in the continuum of care of breast cancer patients in the Indian context.
Cancer Causes Control. 2021 May;32(5):429-440. doi: 10.1007/s10552-021-01399-0. Epub 2021 Feb 2.
10
Prevalence of the use of complementary and alternative medicine in an eastern Indian population with emphasis on tribal/ethnic minority groups.
J Taibah Univ Med Sci. 2018 May 1;13(4):384-389. doi: 10.1016/j.jtumed.2018.04.001. eCollection 2018 Aug.

本文引用的文献

3
Homoeopathy booming in India.
Lancet. 2007 Nov 17;370(9600):1679-80. doi: 10.1016/S0140-6736(07)61709-7.
4
Responding to the threat of chronic diseases in India.
Lancet. 2005 Nov 12;366(9498):1744-9. doi: 10.1016/S0140-6736(05)67343-6.
7
Improving cancer care in India: prospects and challenges.
Asian Pac J Cancer Prev. 2004 Apr-Jun;5(2):226-8.
9
The use and safety of non-allopathic Indian medicines.
Drug Saf. 2002;25(14):1005-19. doi: 10.2165/00002018-200225140-00003.
10
A public health agenda for traditional, complementary, and alternative medicine.
Am J Public Health. 2002 Oct;92(10):1582-91. doi: 10.2105/ajph.92.10.1582.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验